Literature DB >> 31578670

Comparison Between Immuno-Clinicopathological Features of Experimental and Human Visceral Leishmaniasis by Leishmania donovani.

Sheetal Saini1, Anuradha Dube2, Amogh Anant Sahasrabuddhe3, Chandreshwar Prasad Thakur4, Sumit Joshi2, Keerti Rawat3, Ambak Kumar Rai5.   

Abstract

BACKGROUND: Current understanding of visceral leishmaniasis (VL) depends upon the experimental model. Different species of mouse and hamster have been used as model for VL. It is already evident that the mouse model of VL is not a true reflection of the pathology of human visceral leishmaniasis (HuVL). On the other hand, hamster is reported to be a better model of VL to study the progressive as well as chronic pathology of the disease.
OBJECTIVE: To compare immuno-clinicopathological features of experimental VL (ExVL) and HuVL by Leishmania donovani.
METHODS: Hamsters were infected (15 and 60 days) and their immunological, clinical and biochemical parameters were compared with the cases of HuVL.
RESULTS: Splenomegaly and hepatomegaly were observed in infected hamster post-infection, which are hallmarks of symptomatic HuVL cases. Clinical, biochemical and pathological manifestations of infected hamsters were consistent with that of HuVL cases, except parameters such as body weight, uric acid, alkaline phosphatase and random glucose. The absence of clear dichotomy between pro- and anti-inflammatory cytokines was also observed after infection at different sites of infection.
CONCLUSION: Our results suggest that the golden hamster (Mesocricetus auratus), infected via the intracardiac route, constitutes a very good model for the study of experimental Leishmania donovani infections. However, certain differences in clinical presentations of infected hamsters (via intracardiac route) with HuVL suggest further optimization of this animal model like route of infection such as intradermal, which is more close to natural infection.

Entities:  

Keywords:  Experimental model; Human visceral leishmaniasis; Immuno-clinicopathological features; Leishmania donovani; Mesocricetus auratus; Visceral leishmaniasis

Mesh:

Substances:

Year:  2019        PMID: 31578670     DOI: 10.2478/s11686-019-00127-8

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  11 in total

1.  Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.

Authors:  Om Prakash Singh; Kamlesh Gidwani; Rajiv Kumar; Susanne Nylén; Stephen L Jones; Marleen Boelaert; David Sacks; Shyam Sundar
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

2.  Destruction of follicular dendritic cells during chronic visceral leishmaniasis.

Authors:  S C Smelt; C R Engwerda; M McCrossen; P M Kaye
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

3.  The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.

Authors:  P C Melby; B Chandrasekar; W Zhao; J E Coe
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

4.  Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.

Authors:  H W Murray; H Masur; J S Keithly
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.

Authors:  Anuradha Dube; Nasib Singh; Shyam Sundar; Neeloo Singh
Journal:  Parasitol Res       Date:  2005-05-03       Impact factor: 2.289

6.  Characterization of phosphate transporter(s) and understanding their role in Leishmania donovani parasite.

Authors:  K J Sindhu; Amit Kumar Kureel; Sheetal Saini; Smita Kumari; Pankaj Verma; Ambak Kumar Rai
Journal:  Acta Parasitol       Date:  2018-03-26       Impact factor: 1.440

7.  Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.

Authors:  K E Squires; R D Schreiber; M J McElrath; B Y Rubin; S L Anderson; H W Murray
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

8.  Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis.

Authors:  Sandeep Verma; Rajesh Kumar; Gajendra Kumar Katara; Laishram Chandreshwor Singh; Narender Singh Negi; V Ramesh; Poonam Salotra
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

9.  Pi inhibits intracellular accumulation of methylglyoxal in promastigote form of L. donovani.

Authors:  Praachi Tiwari; Pankaj Verma; Amit Kumar Kureel; Sheetal Saini; Ambak Kumar Rai
Journal:  Mol Biochem Parasitol       Date:  2016-06-11       Impact factor: 1.759

10.  Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis.

Authors:  Ambak K Rai; Chandreshwar P Thakur; Amar Singh; Tulika Seth; Sandeep K Srivastava; Pushpendra Singh; Dipendra K Mitra
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

View more
  2 in total

1.  Linoleic Acid-A Feasible Preventive Approach for Visceral Leishmaniasis.

Authors:  Sheetal Saini; Ambak Kumar Rai
Journal:  Front Nutr       Date:  2021-02-26

2.  Linoleic Acid Inhibits the Release of Leishmania donovani Derived Microvesicles and Decreases Its Survival in Macrophages.

Authors:  Sheetal Saini; Ambak Kumar Rai
Journal:  Front Cell Infect Microbiol       Date:  2020-08-07       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.